Latest news with #PennantGroup
Associated Press
3 days ago
- Business
- Associated Press
Excell Celebrates Over 25 Years of Delivering Compassionate Home Care and Hospice Support
06/06/2025, Oklahoma City, Oklahoma // PRODIGY: Feature Story // Excell, a name synonymous with compassionate and comprehensive care in Oklahoma, is celebrating over 25 years in the space. It is a major milestone that marks a journey of purpose, progress, and people-first service. With two distinct divisions: Excell Private Care Services (PCS) and Excell Home Care & Hospice, the company has grown exponentially over the past eight years under the leadership of the Pennant Group, which acquired the organization in 2017. What began as a unified home care and hospice service has evolved into two powerhouse branches operating with a shared mission: to be Oklahoma's one-stop-shop solution for in-home medical support across all ages and stages of life. Excell Private Care Services Since the Pennant Group acquisition, Excell PCS has seen unprecedented growth. Now operating three additional locations across Oklahoma with numerous patient flows annually, this branch has become a trusted resource for families seeking up to 24-hour support for loved ones, whether recovering from surgery, managing chronic illness, or navigating the challenges of aging. With a huge team of skilled professionals, including nurses, caregivers, and case managers, Excell PCS has also introduced new service lines tailored to veterans and families on a budget to ensure high-quality care that isn't reserved only for the privileged few. In an industry often criticized for financial barriers, Excell stands apart by eliminating deposits, upfront nurse visit charges, and long-term contracts. 'When someone is ill or nearing the end of life, it's already an emotional and financial strain,' said Crystal Warner, CEO of Excell PCS. 'We believe care should ease stress, not add to it.' Excell's 24-hour nurse access, critical during the COVID-19 pandemic, remains a cornerstone of its approach, allowing families to avoid unnecessary ER visits and receive immediate advice in the comfort and safety of their homes. Excell Home Care & Hospice On the hospice side, Excell has redefined what end-of-life care looks like in Oklahoma. The organization has expanded its nursing team, built strong community partnerships, and, most importantly, prioritized keeping patients at home longer and out of hospitals. Unlike traditional home health and hospice models, Excell offers 24/7 support, not just to patients but to their families as well, sending caregivers to sit with loved ones so relatives can rest, grieve, or simply breathe. 'Families often fear hospice because it signals the end,' said Kristina Tell, RN and Executive Director of Excell Home Care & Hospice. 'We see it as an opportunity to bring peace, presence, and support when people need it most, without hidden costs or confusing red tape.' Whether serving seniors or younger individuals with terminal conditions, Excell's care plans are individualized, flexible, and always aimed at preserving the dignity of the patient and the well-being of their families. Locally led and operated, Excell's team includes nurses, therapists, aides, social workers, chaplains, volunteers, and administrative staff who see their work as a calling. This internal culture of collaboration translates into external excellence, where patients receive wraparound care, and families feel supported from the first call to the final farewell. Looking ahead, Excell reflects on its over 25 years of service and sees the future is filled with opportunity. The company is actively seeking acquisitions and preparing to open new private care and hospice locations throughout Oklahoma to meet growing demand. 'Our goal is simple,' said Warner. 'We want to continue being Oklahoma's go-to resource for life-changing home care and hospice services, known for accessibility, affordability, and always delivering with heart.' Media Contact Name: Crystal Warner Email: [email protected] Source published by Submit Press Release >> Excell Celebrates Over 25 Years of Delivering Compassionate Home Care and Hospice Support
Yahoo
17-05-2025
- Business
- Yahoo
Pennant Group names Ensign Group CFO Suzanne Snapper to board
The Pennant Group (PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, announced the appointment of Suzanne D. Snapper to its board of directors following her election by a vote of shareholders in connection with the company's annual shareholder meeting. Snapper is the CFO of the Ensign Group (ENSG). Snapper's appointment is effective today, May 16. Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >> Read More on PNTG: Disclaimer & DisclosureReport an Issue Pennant Group Reports Strong Earnings and Growth Pennant Group price target raised to $32 from $28 at Truist Pennant Group Reports Strong Q1 2025 Performance Pennant Group Reports Strong Q1 2025 Financial Results Pennant Group reports Q1 adjusted EPS 27c, consensus 24c
Yahoo
16-05-2025
- Business
- Yahoo
Additional Considerations Required While Assessing Pennant Group's (NASDAQ:PNTG) Strong Earnings
Unsurprisingly, The Pennant Group, Inc.'s (NASDAQ:PNTG) stock price was strong on the back of its healthy earnings report. We did some analysis and think that investors are missing some details hidden beneath the profit numbers. We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. One essential aspect of assessing earnings quality is to look at how much a company is diluting shareholders. In fact, Pennant Group increased the number of shares on issue by 15% over the last twelve months by issuing new shares. As a result, its net income is now split between a greater number of shares. Per share metrics like EPS help us understand how much actual shareholders are benefitting from the company's profits, while the net income level gives us a better view of the company's absolute size. Check out Pennant Group's historical EPS growth by clicking on this link. Pennant Group has improved its profit over the last three years, with an annualized gain of 821% in that time. In comparison, earnings per share only gained 712% over the same period. And the 55% profit boost in the last year certainly seems impressive at first glance. But in comparison, EPS only increased by 43% over the same period. So you can see that the dilution has had a bit of an impact on shareholders. Changes in the share price do tend to reflect changes in earnings per share, in the long run. So it will certainly be a positive for shareholders if Pennant Group can grow EPS persistently. However, if its profit increases while its earnings per share stay flat (or even fall) then shareholders might not see much benefit. For the ordinary retail shareholder, EPS is a great measure to check your hypothetical "share" of the company's profit. That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates. Each Pennant Group share now gets a meaningfully smaller slice of its overall profit, due to dilution of existing shareholders. Therefore, it seems possible to us that Pennant Group's true underlying earnings power is actually less than its statutory profit. But on the bright side, its earnings per share have grown at an extremely impressive rate over the last three years. Of course, we've only just scratched the surface when it comes to analysing its earnings; one could also consider margins, forecast growth, and return on investment, among other factors. Obviously, we love to consider the historical data to inform our opinion of a company. But it can be really valuable to consider what other analysts are forecasting. So feel free to check out our free graph representing analyst forecasts. Today we've zoomed in on a single data point to better understand the nature of Pennant Group's profit. But there are plenty of other ways to inform your opinion of a company. Some people consider a high return on equity to be a good sign of a quality business. While it might take a little research on your behalf, you may find this free collection of companies boasting high return on equity, or this list of stocks with significant insider holdings to be useful. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
08-05-2025
- Business
- Yahoo
Pennant Group First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags
Revenue: US$209.8m (up 34% from 1Q 2024). Net income: US$7.78m (up 59% from 1Q 2024). Profit margin: 3.7% (up from 3.1% in 1Q 2024). The increase in margin was driven by higher revenue. EPS: US$0.23 (up from US$0.16 in 1Q 2024). We check all companies for important risks. See what we found for Pennant Group in our free report. All figures shown in the chart above are for the trailing 12 month (TTM) period Revenue exceeded analyst estimates by 4.2%. Earnings per share (EPS) missed analyst estimates by 4.3%. Looking ahead, revenue is forecast to grow 6.9% p.a. on average during the next 3 years, compared to a 7.0% growth forecast for the Healthcare industry in the US. Performance of the American Healthcare industry. The company's shares are up 8.4% from a week ago. Just as investors must consider earnings, it is also important to take into account the strength of a company's balance sheet. We've done some analysis and you can see our take on Pennant Group's balance sheet. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
07-05-2025
- Business
- Yahoo
The Pennant Group (NASDAQ:PNTG) Beats Expectations in Strong Q1
Senior living provider The Pennant Group (NASDAQ:PNTG) announced better-than-expected revenue in Q1 CY2025, with sales up 33.7% year on year to $209.8 million. Its non-GAAP profit of $0.27 per share was 13.7% above analysts' consensus estimates. Is now the time to buy The Pennant Group? Find out in our full research report. The Pennant Group (PNTG) Q1 CY2025 Highlights: Revenue: $209.8 million vs analyst estimates of $201.5 million (33.7% year-on-year growth, 4.1% beat) Adjusted EPS: $0.27 vs analyst estimates of $0.24 (13.7% beat) Adjusted EBITDA: $16.37 million vs analyst estimates of $14.22 million (7.8% margin, 15.2% beat) Operating Margin: 6%, up from 5% in the same quarter last year Sales Volumes rose 28.9% year on year (34.3% in the same quarter last year) Market Capitalization: $928.4 million 'We are off to a strong start in 2025,' said Brent Guerisoli, the Company's Chief Executive Officer. Company Overview Spun off from The Ensign Group in 2019 to focus on non-skilled nursing healthcare services, Pennant Group (NASDAQ:PNTG) operates home health, hospice, and senior living facilities across 13 western and midwestern states, serving patients of all ages including seniors. Sales Growth Reviewing a company's long-term sales performance reveals insights into its quality. Even a bad business can shine for one or two quarters, but a top-tier one grows for years. Thankfully, The Pennant Group's 16.2% annualized revenue growth over the last five years was solid. Its growth beat the average healthcare company and shows its offerings resonate with customers. The Pennant Group Quarterly Revenue Long-term growth is the most important, but within healthcare, a half-decade historical view may miss new innovations or demand cycles. The Pennant Group's annualized revenue growth of 24.1% over the last two years is above its five-year trend, suggesting its demand was strong and recently accelerated. The Pennant Group Year-On-Year Revenue Growth We can better understand the company's revenue dynamics by analyzing its number of admissions, which reached 18,878 in the latest quarter. Over the last two years, The Pennant Group's admissions averaged 25.1% year-on-year growth. Because this number is in line with its revenue growth, we can see the company kept its prices fairly consistent. The Pennant Group Admissions This quarter, The Pennant Group reported wonderful year-on-year revenue growth of 33.7%, and its $209.8 million of revenue exceeded Wall Street's estimates by 4.1%. Looking ahead, sell-side analysts expect revenue to grow 13.4% over the next 12 months, a deceleration versus the last two years. Still, this projection is noteworthy and implies the market is forecasting success for its products and services.
